Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
复制标题
A041202 研究的后续研究表明，依鲁替尼疗法对患有 CLL 的老年患者持续有效。
DOI：
10.1182/blood.2023021959
复制
发表时间：
2024
期刊：
影响因子：
20.3
通讯作者：
Brown,Jenn
中科院分区：
文献类型：
--
作者：
Woyach,JenniferA;PerezBurbano,Gabriela;Ruppert,AmyS;Miller,Cecelia;Heerema,NylaA;Zhao,Weiqiang;Wall,Anna;Ding,Wei;Bartlett,NancyL;Brander,DanielleM;Barr,PaulM;Rogers,KerryA;Parikh,SameerA;Stephens,DeborahM;Brown,Jenn
